ANK3: Ankyrin-3 Gene – Key Roles in Neuronal Development and Bipolar Disorder
Comprehensive biomedical overview of ANK3, encoding ankyrin-G, with clinical relevance to neuropsychiatric disorders and cancer.
Gene Information Card
| Symbol | ANK3 |
|---|---|
| Full Name | Ankyrin 3 |
| Gene Type | Protein coding |
| Chromosomal Location | 10q21.2 |
| NCBI Gene ID | 288 ncbi.nlm.nih.gov/gene/288 |
| Ensembl ID | ENSG00000157510 |
| UniProt ID | Q12955 |
| OMIM ID | 600465 |
| HGNC ID | 494 |
| Aliases | ANK-3, ankyrin-G, MRT37 |
Description
ANK3 encodes ankyrin-G, a member of the ankyrin family that links integral membrane proteins to the spectrin-actin cytoskeleton. Ankyrin-G is essential for the clustering of voltage-gated sodium channels at axon initial segments and nodes of Ranvier, and plays critical roles in neuronal polarity, synaptic plasticity, and cardiac excitability. Variants in ANK3 are strongly associated with bipolar disorder, schizophrenia, and autism spectrum disorders.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Bipolar disorder | Disruption of ankyrin-G scaffolding at axon initial segments alters neuronal excitability and signaling | GWAS: Ferreira et al. 2008, PMID: 18179893 |
| Autism spectrum disorder | Rare de novo loss-of-function variants impair synaptic organization | Exome sequencing: Iossifov et al. 2014, PMID: 25363760 |
| Schizophrenia | Common variants affect ANK3 expression and sodium channel clustering | PGC meta-analysis: Schizophrenia Working Group 2014, PMID: 25056061 |
| Intellectual disability | Homozygous truncating mutations cause MRT37 with severe cognitive impairment | OMIM #615493, PMID: 23934111 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain (cerebral cortex) | 33.2 | High |
| Cerebellum | 28.5 | High |
| Heart | 12.1 | Medium |
| Skeletal muscle | 8.4 | Medium |
| Liver | 2.3 | Low |
| Kidney | 5.7 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (neuroblastoma) | 45.6 | Neuronal model |
| U-87 MG (glioblastoma) | 38.2 | Glial origin |
| HEK 293 (embryonic kidney) | 12.0 | Low endogenous expression |
| HepG2 (hepatocellular carcinoma) | 3.1 | Minimal expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.427C>T (p.Arg143*) | Nonsense | Rare | Loss of function; associated with intellectual disability |
| c.3892G>A (p.Glu1298Lys) | Missense | 0.01% (gnomAD) | Alters spectrin-binding domain; bipolar disorder risk |
| c.5410_5411del (p.Leu1804Valfs*3) | Frameshift | Rare | Truncation; autism spectrum disorder |
| rs9804190 (intronic) | SNV | Common (MAF 0.35) | Expression QTL; bipolar disorder GWAS hit |
Mutation functional classification
Loss of Function (LOF)
Nonsense and frameshift mutations (e.g., p.Arg143*, p.Leu1804Valfs*3) lead to haploinsufficiency or truncated protein, impairing cytoskeletal anchoring and ion channel clustering.
Gain of Function (GOF)
No well-characterized gain-of-function mutations reported in ANK3.
Dominant Negative (DN)
Some missense variants in the spectrin-binding domain may interfere with wild-type ankyrin-G function, but dominant-negative effects are not firmly established.
View complete mutation data:
Gene Ontology (GO)
| • GO:0005856 – cytoskeleton | • GO:0008092 – cytoskeletal protein binding |
| • GO:0030507 – spectrin binding | • GO:0045202 – synapse |
| • GO:0043197 – dendritic spine | • GO:0001518 – voltage-gated sodium channel clustering |
| • GO:0043025 – neuronal cell body | • GO:0005886 – plasma membrane |
Pathways
• REACTOME: R-HSA-5576892 – Phase 0 – rapid depolarisation
• REACTOME: R-HSA-5576893 – Phase 1 – inactivation of fast Na+ channels
• REACTOME: R-HSA-112316 – Neuronal System
• KEGG: hsa05414 – Dilated cardiomyopathy (ankyrin-G role in cardiac conduction)
Protein Summary
Ankyrin-G (UniProt Q12955) is a 4801-amino acid protein with multiple isoforms. It contains an N-terminal membrane-binding domain (MBD) that interacts with ion channels and cell adhesion molecules, a spectrin-binding domain (SBD) that links to the cytoskeleton, and a C-terminal regulatory domain. Ankyrin-G is critical for the assembly and maintenance of the axon initial segment and nodes of Ranvier, where it clusters voltage-gated sodium channels (Nav1.2, Nav1.6) and neurofascin. It also organizes the cardiac intercalated disc and is implicated in bipolar disorder, autism, and cardiac arrhythmias.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SHANK3 Knockout HEK293 Cell Line | EDJ-KQ2753 | Human | 85358 | Details Get a Quote |
| KANK3 Knockout HEK293 Cell Line | EDJ-KQ11850 | Human | 256949 | Details Get a Quote |
| ANK3 Knockout HEK293 Cell Line | EDJ-KQ12041 | Human | 288 | Details Get a Quote |
| SHANK3 Knockout A-549 Cell Line | EDJ-KQ25033 | Human | 85358 | Details Get a Quote |
| SHANK3 Knockout HCT 116 Cell Line | EDJ-KQ25034 | Human | 85358 | Details Get a Quote |
| SHANK3 Knockout HeLa Cell Line | EDJ-KQ25035 | Human | 85358 | Details Get a Quote |
| KANK3 Knockout A-549 Cell Line | EDJ-KQ40274 | Human | 256949 | Details Get a Quote |
| KANK3 Knockout HCT 116 Cell Line | EDJ-KQ40275 | Human | 256949 | Details Get a Quote |
| ANK3 Knockout A-549 Cell Line | EDJ-KQ40670 | Human | 288 | Details Get a Quote |
| ANK3 Knockout HCT 116 Cell Line | EDJ-KQ40671 | Human | 288 | Details Get a Quote |
| ANK3 Knockout HeLa Cell Line | EDJ-KQ40672 | Human | 288 | Details Get a Quote |
| PANK3 Knockout HEK293 Cell Line | EDJ-KQ51688 | Human | 79646 | Details Get a Quote |
| PANK3 Knockout HeLa Cell Line | EDJ-KQ57198 | Human | 79646 | Details Get a Quote |
| KANK3 Knockout HeLa Cell Line | EDJ-KQ59313 | Human | 256949 | Details Get a Quote |
| PANK3 Knockout A-549 Cell Line | EDJ-KQ65710 | Human | 79646 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records